• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 PROLONG 研究中,首次特发性深静脉血栓形成后抗凝治疗停药后复发的危险因素:单纯残留静脉阻塞,以及与 D-二聚体联合存在。

Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.

机构信息

Department of Angiology & Blood Coagulation Marino Golinelli, University Hospital S. Orsola-Malpighi, Via Albertoni, 15 Bologna, Italy.

出版信息

Eur J Vasc Endovasc Surg. 2010 Mar;39(3):356-65. doi: 10.1016/j.ejvs.2009.11.022. Epub 2010 Jan 19.

DOI:10.1016/j.ejvs.2009.11.022
PMID:20034816
Abstract

OBJECTIVE

This study aims to assess the predictive value of residual venous obstruction (RVO) for recurrent venous thrombo-embolism (VTE) in a study using D-dimer to predict outcome.

DESIGN

This is a multicentre randomised open-label study.

METHODS

Patients with a first episode of idiopathic VTE were enrolled on the day of anticoagulation discontinuation when RVO was determined by compression ultrasonography in those with proximal deep vein thrombosis (DVT) of the lower limbs. D-dimer was measured after 1 month. Patients with normal D-dimer did not resume anticoagulation while patients with abnormal D-dimer were randomised to resume anticoagulation or not. The primary outcome measure was recurrent VTE over an 18-month follow-up.

RESULTS

A total of 490 DVT patients were analysed (after excluding 19 for different reasons and 118 for isolated pulmonary embolism (PE)). Recurrent DVT occurred in 19% (19/99) of patients with abnormal D-dimer who did not resume anticoagulation and 10% (31/310) in subjects with normal D-dimer (adjusted hazard ratio: 2.1; p = 0.02). Recurrences were similar in subjects either with (11%, 17/151) or without RVO (13%, 32/246). Recurrent DVT rates were also similar for normal D-dimer, with or without RVO, and for abnormal D-dimer, with or without RVO.

CONCLUSIONS

Elevated D-dimer at 1 month after anticoagulation withdrawal is a risk factor for recurrence, while RVO at the time of anticoagulation withdrawal is not.

摘要

目的

本研究旨在评估在使用 D-二聚体预测结局的研究中,残余静脉阻塞(RVO)对复发性静脉血栓栓塞(VTE)的预测价值。

设计

这是一项多中心随机开放标签研究。

方法

在下肢近端深静脉血栓形成(DVT)患者停止抗凝治疗的当天,通过压迫超声检查确定 RVO 后,招募首次发生特发性 VTE 的患者。在 1 个月后测量 D-二聚体。D-二聚体正常的患者不再继续抗凝,而 D-二聚体异常的患者随机分为继续或不继续抗凝。主要观察指标是 18 个月随访期间的复发性 VTE。

结果

共分析了 490 例 DVT 患者(排除了 19 例因不同原因和 118 例单纯肺栓塞(PE))。D-二聚体异常且未继续抗凝的患者中有 19%(19/99)发生复发性 DVT,D-二聚体正常的患者中有 10%(31/310)发生复发性 DVT(调整后的危险比:2.1;p=0.02)。有或无 RVO 的患者中复发性 DVT 的发生率相似(11%,17/151;13%,32/246)。D-二聚体正常且有或无 RVO、D-二聚体异常且有或无 RVO 的患者中复发性 DVT 的发生率也相似。

结论

抗凝治疗停止后 1 个月 D-二聚体升高是复发的危险因素,而抗凝治疗停止时的 RVO 不是。

相似文献

1
Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.在 PROLONG 研究中,首次特发性深静脉血栓形成后抗凝治疗停药后复发的危险因素:单纯残留静脉阻塞,以及与 D-二聚体联合存在。
Eur J Vasc Endovasc Surg. 2010 Mar;39(3):356-65. doi: 10.1016/j.ejvs.2009.11.022. Epub 2010 Jan 19.
2
D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis.D-二聚体和残留静脉阻塞作为首发诱因性深静脉血栓患者抗凝治疗停药期间和停药后复发的风险因素。
Thromb Haemost. 2011 May;105(5):837-45. doi: 10.1160/TH10-08-0559. Epub 2011 Feb 28.
3
D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.D-二聚体水平联合残余静脉阻塞与首次特发性深静脉血栓形成抗凝治疗停药后的复发风险
Thromb Haemost. 2005 Nov;94(5):969-74. doi: 10.1160/TH05-02-0095.
4
Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy.肺栓塞患者的复发风险:D-二聚体和肺闪烁显像残留灌注缺损的预测作用。
Thromb Haemost. 2013 Feb;109(2):181-6. doi: 10.1160/TH12-07-0534. Epub 2012 Nov 29.
5
D-Dimer Levels and Vitamin K Antagonist Therapy in Deep Vein Thrombosis of the Legs.腿部深静脉血栓形成中的D-二聚体水平与维生素K拮抗剂治疗
Ann Vasc Surg. 2016 Jul;34:119-34. doi: 10.1016/j.avsg.2015.11.038. Epub 2016 May 10.
6
D-dimer testing to determine the duration of anticoagulation therapy.D-二聚体检测以确定抗凝治疗的持续时间。
N Engl J Med. 2006 Oct 26;355(17):1780-9. doi: 10.1056/NEJMoa054444.
7
Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.静脉血栓栓塞复发风险:停用口服抗凝药后检测D - 二聚体具有较高的阴性预测价值。
Thromb Haemost. 2002 Jan;87(1):7-12.
8
Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.残余静脉血栓形成及连续D-二聚体检测在深静脉血栓形成患者长期管理中的应用
Thromb Res. 2017 Jun;154:35-41. doi: 10.1016/j.thromres.2017.04.002. Epub 2017 Apr 4.
9
Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.促血栓形成的纤维蛋白凝块表型与抗凝治疗中断后复发性肺栓塞相关。
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):365-373. doi: 10.1161/ATVBAHA.116.308253. Epub 2016 Dec 29.
10
D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.对于首次特发性深静脉血栓形成,抗凝治疗停药后,D-二聚体和凝血因子VIII是复发的独立危险因素。
Thromb Res. 2008;122(5):610-7. doi: 10.1016/j.thromres.2007.12.024. Epub 2008 Mar 4.

引用本文的文献

1
The clinical outcomes of different doses of rivaroxaban in patients with isolated distal deep vein thrombosis.不同剂量利伐沙班治疗单纯性远端下肢深静脉血栓的临床转归。
J Vasc Surg Venous Lymphat Disord. 2024 Mar;12(2):101653. doi: 10.1016/j.jvsv.2023.07.008. Epub 2023 Jul 23.
2
Safety and efficacy of a Siddha Medicine fixed regimen for the treatment of asymptomatic and mild COVID-19 patients.一种悉达医学固定疗程治疗无症状和轻症新冠肺炎患者的安全性和有效性。
J Ayurveda Integr Med. 2022 Jul-Sep;13(3):100589. doi: 10.1016/j.jaim.2022.100589. Epub 2022 May 23.
3
Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction.
在采用包含残余静脉阻塞的个体化抗凝治疗的深静脉血栓形成患者中复发的危险因素。
Res Pract Thromb Haemost. 2018 Feb 3;2(2):299-309. doi: 10.1002/rth2.12079. eCollection 2018 Apr.
4
Predictive Value of Mean Platelet Volume for Pulmonary Embolism Recurrence.平均血小板体积对肺栓塞复发的预测价值。
Lung. 2017 Aug;195(4):497-502. doi: 10.1007/s00408-017-0020-7. Epub 2017 Jun 15.
5
Residual Vein Thrombosis Echogenicity Is Associated to the Risk of DVT Recurrence: A Cohort Study.残余静脉血栓回声与深静脉血栓复发风险相关:一项队列研究。
Clin Appl Thromb Hemost. 2018 Apr;24(3):477-482. doi: 10.1177/1076029617700997. Epub 2017 Apr 10.
6
Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?对于不明原因的静脉血栓栓塞症,是否应重新审视终身抗凝治疗?
Thromb J. 2015 Oct 5;13:33. doi: 10.1186/s12959-015-0063-z. eCollection 2015.
7
Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation.静脉血栓栓塞症:预测复发及长期抗凝需求
Vasc Med. 2015 Apr;20(2):143-52. doi: 10.1177/1358863X14566429.
8
Predicting the risk of recurrent venous thromboembolism (VTE).预测复发性静脉血栓栓塞(VTE)的风险。
J Thromb Thrombolysis. 2015 Apr;39(3):353-66. doi: 10.1007/s11239-015-1188-4.
9
The prediction role of D-dimer in recurrence of venous thromboembolism 1-year after anticoagulation discontinuing following idiopathic deep vein thrombosis.D-二聚体在特发性深静脉血栓形成抗凝治疗停止1年后静脉血栓栓塞复发中的预测作用
J Res Med Sci. 2014 Jul;19(7):586-91.
10
A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study.一项旨在为随机对照试验设计提供信息的可行性研究,以确定在癌症相关性血栓形成(ALICAT)治疗中使用低分子量肝素的最具临床和成本效益的抗凝时间:一项混合方法研究的研究方案。
Trials. 2014 Apr 12;15:122. doi: 10.1186/1745-6215-15-122.